Catalytic Asymmetric Synthesis

The development of chiral catalysts by William Knowles, Ryoji Noyori, and K. Barry Sharpless revolutionized pharmaceutical manufacturing by enabling the selective production of single mirror-image molecules. Sharpless's asymmetric epoxidation achieves enantiomeric excesses exceeding 99%, a standard that is 30% higher than the typical rival catalytic methods of the 1970s. This innovation, which earned the 2001 Nobel Prize in Chemistry, outperforms #9 Discovery of Oxygen in immediate drug industry value, as it now produces over 80% of new chiral medications with tailored three-dimensional shapes.